We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Boehringer Ingelheim Limited

The Hyde Building, 4th Floor, The Park, Carrickmines, Dublin 18,
Telephone: +353 1 2959620
Fax: +353 1 2959624
Medical Information e-mail: Medinfo@dbl.boehringer-ingelheim.com
Patient Information Leaflet last updated on medicines.ie: 29/10/2013
PIL Twynsta 40 mg/5 mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 29/10/2013 and displayed until Current
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 12/09/2013 and displayed until 29/10/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
Updated on 03/12/2012 and displayed until 12/09/2013
Reasons for adding or updating:
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
Updated on 16/07/2012 and displayed until 03/12/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Change to appearance of the medicine
  • Change to MA holder contact details
Updated on 14/07/2011 and displayed until 16/07/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 05/01/2011 and displayed until 14/07/2011
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Telmisartan
   Amlodipine besilate